Abstract
Incidence of human papillomavirus (HPV)-associated oral cancers is on the rise. However, epidemiological data of this subset of cancers are limited. Dental hospital poses a unique advantage in detection of HPV-positive oral malignancies. We assessed the utility of formalin-fixed paraffin-embedded (FFPE) tissues, which are readily available, for evaluation of high-risk HPV infection in oral cancer. For protocol standardization, we used 20 prospectively collected paired FFPE and fresh tissues of histopathologically confirmed oral cancer cases reported in Oral Medicine department of a dental hospital for comparative study. Only short PCRs (~ 200 bp) of DNA isolated using a modified xylene-free method displayed a concordant HPV result. For HPV analysis, we used additional 30 retrospectively collected FFPE tissues. DNA isolated from these specimens showed an overall 23.4% (11/47) HPV positivity with detection of HPV18. Comparison of HPV positivity from dental hospital FFPE specimens with overall HPV positivity of freshly collected oral cancer specimens (n = 55) from three cancer care hospitals of the same region showed notable difference (12.7%; 7/55). Further, cancer hospital specimens showed HPV16 positivity and displayed a characteristic difference in reported sub-sites and patient spectrum. Overall, using a xylene-free FFPE DNA isolation method clubbed with short amplicon PCR, we showed detection of HPV-positive oral cancer in dental hospitals.
Similar content being viewed by others
Availability of data and material
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.
Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, Jha P, et al. Cancer mortality in India: a nationally representative survey. Lancet. 2012;379(9828):1807–16. https://doi.org/10.1016/S0140-6736(12)60358-4.
Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Sidransky D, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332(11):712–7. https://doi.org/10.1056/NEJM199503163321104.
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Sidransky D, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709–20.
Aggarwal N, Yadav J, Thakur K, Bibban R, Chhokar A, Tripathi T, Bharti AC, et al. Human papillomavirus infection in head and neck squamous cell carcinomas: transcriptional triggers and changed disease patterns. Front Cell Infect Microbiol. 2020;10: 537650. https://doi.org/10.3389/fcimb.2020.537650.
Gillison ML, Castellsague X, Chaturvedi A, Goodman MT, Snijders P, Tommasino M, Franceschi S, et al. Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int J Cancer. 2014;134(3):497–507. https://doi.org/10.1002/ijc.28201.
Syrjanen S, Rautava J, Syrjanen K. HPV in Head and Neck Cancer-30 Years of History. Recent Results Cancer Res. 2017;206:3–25. https://doi.org/10.1007/978-3-319-43580-0_1.
Lesnikova I, Lidang M, Hamilton-Dutoit S, Koch J. Rapid, sensitive, type specific PCR detection of the E7 region of human papillomavirus type 16 and 18 from paraffin embedded sections of cervical carcinoma. Infect Agent Cancer. 2010;5:2. https://doi.org/10.1186/1750-9378-5-2.
Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121(8):1813–20. https://doi.org/10.1002/ijc.22851.
Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, et al. Molecular classification identifies a subset of human papillomavirus–associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24(5):736–47. https://doi.org/10.1200/JCO.2004.00.3335.
Westra WH. Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol. 2014;50(9):771–9. https://doi.org/10.1016/j.oraloncology.2014.05.004.
Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781–9. https://doi.org/10.1016/S1470-2045(10)70017-6.
Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110(7):1429–35. https://doi.org/10.1002/cncr.22963.
Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Gillison ML, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550–9. https://doi.org/10.1200/JCO.2013.50.3870.
Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612–9. https://doi.org/10.1200/JCO.2007.14.1713.
Machado J, Reis PP, Zhang T, Simpson C, Xu W, Perez-Ordonez B, et al. Low prevalence of human papillomavirus in oral cavity carcinomas. Head Neck Oncol. 2010;2:6.
Castellsague X, Alemany L, Quer M, Halec G, Quiros B, Tous S, et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016;108(6):403. https://doi.org/10.1093/jnci/djv403.
Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, Herbrink P, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol. 1996;34(3):745–7.
Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, Chan SY. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers–high prevalence and multiplicity of infections. Int J Cancer. 1995;61(4):450–4.
Chang JY, Lin MC, Chiang CP. High-risk human papillomaviruses may have an important role in non-oral habits-associated oral squamous cell carcinomas in Taiwan. Am J Clin Pathol. 2003;120(6):909–16. https://doi.org/10.1309/C5P6-NUQ2-NW6L-CTBP.
Dhanapal R, Ranganathan K, Kondaiah P, Devi RU, Joshua E, Saraswathi TR. High-risk human papilloma virus in archival tissues of oral pathosis and normal oral mucosa. Contemp Clin Dent. 2015;6(2):148–52. https://doi.org/10.4103/0976-237X.156033.
Gan LL, Zhang H, Guo JH, Fan MW. Prevalence of human papillomavirus infection in oral squamous cell carcinoma: a case-control study in Wuhan, China. Asian Pac J Cancer Prev. 2014;15(14):5861–5.
Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005;365(9475):1927–33. https://doi.org/10.1016/S0140-6736(05)66658-5.
Lim K, Moles DR, Downer MC, Speight PM. Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study. Br Dent J. 2003;194(9):497–502. https://doi.org/10.1038/sj.bdj.4810069 (discussion 493).
McGurk M, Scott SE. The reality of identifying early oral cancer in the general dental practice. Br Dent J. 2010;208(8):347–51. https://doi.org/10.1038/sj.bdj.2010.345.
Cannavo I, Loubatier C, Chevallier A, Giordanengo V. Improvement of DNA extraction for human papillomavirus genotyping from formalin-fixed paraffin-embedded tissues. Biores Open Access. 2012;1(6):333–7. https://doi.org/10.1089/biores.2012.0241.
Hatakeyama H, Mizumachi T, Sakashita T, Kano S, Homma A, Fukuda S. Epithelial-mesenchymal transition in human papillomavirus-positive and -negative oropharyngeal squamous cell carcinoma. Oncol Rep. 2014;32(6):2673–9. https://doi.org/10.3892/or.2014.3509.
Mishra A, Bharti AC, Varghese P, Saluja D, Das BC. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Int J Cancer. 2006;119(12):2840–50.
Odida M, de Sanjose S, Sandin S, Quiros B, Alemany L, Lloveras B, et al. Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer. Infect Agent Cancer. 2010;5:15. https://doi.org/10.1186/1750-9378-5-15.
Kocjan BJ, Hosnjak L, Poljak M. Detection of alpha human papillomaviruses in archival formalin-fixed, paraffin-embedded (FFPE) tissue specimens. J Clin Virol. 2015;76(Suppl 1):S88–97. https://doi.org/10.1016/j.jcv.2015.10.007.
Cai L, Yu SZ, Zhang ZF. Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: a case-control study. World J Gastroenterol. 2001;7(4):506–9.
Yu FL, Zheng WY, Wang MY, Bender W, Cheerva A, Miller J. The effect of 17beta-estradiol-DNA adducts on the replication of exon # 5 of the human suppressor gene p53. FEBS Lett. 1999;454(1–2):7–10.
QSS. Human Papillomavirus Laboratory Manual. 1st ed. Geneva: World Health Organization; 2010.
Jacobs MV, de RodaHusman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol. 1995;33(4):901–5.
Storey A, Oates D, Banks L, Crawford L, Crook T. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16. Nucleic Acids Res. 1991;19(15):4109–14.
Shukla S, Bharti AC, Mahata S, Hussain S, Hedau S, Sharma R, et al. Application of a Multiplex PCR to cervical cells collected by a paper smear for the simultaneous detection of all mucosal human papillomaviruses and typing of HR HPV types 16 and 18. J Med Microbiol. 2010;59(11):1303–10. https://doi.org/10.1099/jmm.0.019240-0.
Shukla S, Shishodia G, Mahata S, Hedau S, Pandey A, Bhambhani S, et al. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Mol Cancer. 2010;9:282.
Coombs NJ, Gough AC, Primrose JN. Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res. 1999;27(16):12.
Karlsen F, Kalantari M, Chitemerere M, Johansson B, Hagmar B. Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest. 1994;71(4):604–11.
Palmer E, Newcombe RG, Green AC, Kelly C, Noel Gill O, Hall G, et al. Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: implications for tonsil cancer precursor lesions. Int J Cancer. 2014;135(10):2437–43. https://doi.org/10.1002/ijc.28886.
Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, Manos MM. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst. 1990;82(18):1477–84.
Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Graves D, Weichselbaum RR, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res. 1996;2(4):755–62.
Settle K, Posner MR, Schumaker LM, Tan M, Suntharalingam M, Goloubeva O, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila). 2009;2(9):776–81. https://doi.org/10.1158/1940-6207.CAPR-09-0149.
Jalouli J, Ibrahim SO, Mehrotra R, Jalouli MM, Sapkota D, Larsson PA, Hirsch JM. Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol. 2010;130(11):1306–11. https://doi.org/10.3109/00016481003782041.
Kocjan BJ, Maver PJ, Hosnjak L, Zidar N, Odar K, Gale N, Poljak M. Comparative evaluation of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for detecting and identifying human papillomaviruses in archival tissue specimens of head and neck cancers. Acta Dermatovenerol Alp Pannonica Adriat. 2012;21(4):73–5.
Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn LJ, Quint W, Kato I, et al. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study. Int J Cancer. 2012;131(5):1179–86. https://doi.org/10.1002/ijc.26500.
Thibaudeau E, Fortin B, Coutlee F, Nguyen-Tan P, Weng X, Audet ML, et al. HPV prevalence and prognostic value in a prospective cohort of 255 patients with locally advanced HNSCC: a single-centre experience. Int J Otolaryngol. 2013;2013: 437815. https://doi.org/10.1155/2013/437815.
Erhart SM, Rivero ER, Bazzo ML, Onofre AS. Comparative evaluation of the GP5+/6+, MY09/11 and PGMY09/11 primer sets for HPV detection by PCR in oral squamous cell carcinomas. Exp Mol Pathol. 2015;100(1):13–6. https://doi.org/10.1016/j.yexmp.2015.11.024.
Bonin S, Stanta G. Nucleic acid extraction methods from fixed and paraffin-embedded tissues in cancer diagnostics. Expert Rev Mol Diagn. 2013;13(3):271–82. https://doi.org/10.1586/erm.13.14.
Snijders PJ, Heideman DA, Meijer CJ. Methods for HPV detection in exfoliated cell and tissue specimens. APMIS. 2010;118(6–7):520–8. https://doi.org/10.1111/j.1600-0463.2010.02621.x.
Gupta S, Kumar P, Kaur H, Sharma N, Saluja D, Bharti AC, Das BC. Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer. Sci Rep. 2015;5:16811. https://doi.org/10.1038/srep16811.
Odida M, de Sanjose S, Quint W, Bosch XF, Klaustermeier J, Weiderpass E. Human Papillomavirus type distribution in invasive cervical cancer in Uganda. BMC Infect Dis. 2008;8:85. https://doi.org/10.1186/1471-2334-8-85.
Gupta S, Kumar P, Kaur H, Sharma N, Gupta S, Saluja D, Das B, et al. Constitutive activation and overexpression of NF-kappaB/c-Rel in conjunction with p50 contribute to aggressive tongue tumorigenesis. Oncotarget. 2018;9(68):33011–29. https://doi.org/10.18632/oncotarget.26041.
Verma G, Vishnoi K, Tyagi A, Jadli M, Singh T, Goel A, et al. Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers. Cancer Med. 2017;6(3):591–604. https://doi.org/10.1002/cam4.983.
Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Singh M, Singh M. Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J. 2010;7:253. https://doi.org/10.1186/1743-422X-7-253.
Ghosh A, Ghosh S, Maiti GP, Sabbir MG, Alam N, Sikdar N, Panda CK, et al. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit. J Pathol. 2009;217(3):408–19. https://doi.org/10.1002/path.2464.
Mitra S, Banerjee S, Misra C, Singh RK, Roy A, Sengupta A, et al. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population. J Clin Pathol. 2007;60(9):1040–7. https://doi.org/10.1136/jcp.2005.034835.
Pal P, Raychowdhury R, Basu S, Gure PK, Das S, Halder A. Cytogenetic and micronuclei study of human papillomavirus-related oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2018;22(3):335–40. https://doi.org/10.4103/jomfp.JOMFP_269_17.
Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer. 2002;97(5):649–53. https://doi.org/10.1002/ijc.10112.
Kulkarni SS, Kulkarni SS, Vastrad PP, Kulkarni BB, Markande AR, Kadakol GS, et al. Prevalence and distribution of high risk human papillomavirus (HPV) Types 16 and 18 in Carcinoma of cervix, saliva of patients with oral squamous cell carcinoma and in the general population in Karnataka, India. Asian Pac J Cancer Prev. 2011;12(3):645–8.
Bandhary SK, Shetty V, Saldanha M, Gatti P, Devegowda D, Shetty AK. Detection of human papilloma virus and risk factors among patients with head and neck squamous cell carcinoma attending a tertiary referral centre in South India. Asian Pac J Cancer Prev. 2018;19(5):1325–30. https://doi.org/10.22034/APJCP.2018.19.5.1325.
Ramshankar V, Soundara VT, Shyamsundar V, Ramani P, Krishnamurthy A. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac J Cancer Prev. 2014;15(19):8351–9. https://doi.org/10.7314/apjcp.2014.15.19.8351.
D’Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol. 1998;34(5):413–20. https://doi.org/10.1016/s1368-8375(98)00028-1.
Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467–75. https://doi.org/10.1158/1055-9965.EPI-04-0551.
Shi W, Kato H, Perez-Ordonez B, Pintilie M, Huang S, Hui A, Liu FF, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol. 2009;27(36):6213–21. https://doi.org/10.1200/JCO.2009.23.1670.
Boy S, Van Rensburg EJ, Engelbrecht S, Dreyer L, van Heerden M, van Heerden W. HPV detection in primary intra-oral squamous cell carcinomas–commensal, aetiological agent or contamination? J Oral Pathol Med. 2006;35(2):86–90. https://doi.org/10.1111/j.1600-0714.2006.00385.x.
Bark R, Mercke C, Munck-Wikland E, Wisniewski NA, Hammarstedt-Nordenvall L. Cancer of the gingiva. Eur Arch Otorhinolaryngol. 2016;273(6):1335–45. https://doi.org/10.1007/s00405-015-3516-x.
Ilhan B, Lin K, Guneri P, Wilder-Smith P. Improving oral cancer outcomes with imaging and artificial intelligence. J Dent Res. 2020;99(3):241–8. https://doi.org/10.1177/0022034520902128.
Quintero K, Giraldo GA, Uribe ML, Baena A, Lopez C, Alvarez E, Sanchez GI. Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia. Braz J Otorhinolaryngol. 2013;79(3):375–81. https://doi.org/10.5935/1808-8694.20130065.
Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol. 2006;24(17):2606–11. https://doi.org/10.1200/JCO.2006.06.1291.
Syrjanen S, Lodi G, von Bultzingslowen I, Aliko A, Arduino P, Campisi G, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011;17(Suppl 1):58–72. https://doi.org/10.1111/j.1601-0825.2011.01792.x.
Patel KR, Vajaria BN, Begum R, Desai A, Patel JB, Shah FD, et al. Prevalence of high-risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India. J Oral Pathol Med. 2014;43(4):293–7. https://doi.org/10.1111/jop.12147.
Funding
The study was supported by research grants from Department of Biotechnology (DBT:6242-P34/RGCB/PMD/DBT/ALCB/2015) and Indian Council of Medical Research (ICMR:HIV/50/139/20101-ECDII), Government of India, DST-SERB (EMR/2017/004018/BBM), Institution of Eminence University of Delhi (Ref. No./IoE/2021/12/FRP) to ACB, and UGC-Junior Research Fellowship to GV and KV [F.2-2/2009 (SA-I)], grant from ICMR to AT (81/3/2009/BMS/Stem Cell) and MJ (3/2/2/278/2014/NCDIII), UGC-Junior Research Fellowship to TS (2061430699 22/06/2014 (i) EU-V), grant from CSIR to NA (17/12/2017 (ii) EU-V), and grant from CCRH to ACB:SC (17-51/2016-17/CCRH/Tech/Coll./DU-Cervical Cancer.4850) are also thankfully acknowledged.
Author information
Authors and Affiliations
Contributions
GV participated in the study design and performed major experimental work and manuscript preparation; NA and SC helped in final preparation of manuscript, communication, and revision; AT assisted in experimental work and data analysis; KV, MJ, and TS helped in experimental work and manuscript preparation; AG, DP, AS, KA, US, and DCD participated in the enrollment of study subjects, their clinical evaluation, provided staging, histopathological grading, tumor diagnosis, and specimen collection; SS participated in the statistical evaluation of data; RM and SMS performed evaluation of clinical and experimental data and assisted in critical review of the manuscript; ACB conceived and designed the study, evaluated data, and critically reviewed, drafted, and communicated the final manuscript. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflict of interest.
Ethical approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Verma, G., Aggarwal, N., Chhakara, S. et al. Detection of human papillomavirus infection in oral cancers reported at dental facility: assessing the utility of FFPE tissues. Med Oncol 39, 13 (2022). https://doi.org/10.1007/s12032-021-01608-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12032-021-01608-5